Pet evaluation of inflammatory process in Takayasu's arteritis;Determinación de actividad inflamatoria en pacientes con arteritis de Takayasu mediante tomografía por emisión de positrones (PET)

Archivos de Cardiologia de Mexico

Volumn 80, Issue 4, 2010, Pages 235-241

  Ricalde Alcocer, Alejandro ^a   Soto López, María Elena ^a   Reyes, Pedro ^a   Mendoza, Guillermo ^b   Cruz, Patricio ^b   Meave González, Aloha ^a,b   Ochoa, Juan Manuel ^b   Jácome, Rodrigo ^b   Peña Cabral, Marco Antonio ^b   Alexánderson Rosas, Erick ^a,b  

^a INSTITUTO NACIONAL DE CARDIOLOGÍA IGNACIO CHÁVEZ   (Mexico)

^b UNIVERSIDAD NACIONAL AUTÓNOMA DE MÉXICO   (Mexico)

Author keywords

18F fluorodeoxyglucose; Mexico; Positron emission tomography; Takayasu arteritis

Indexed keywords

C REACTIVE PROTEIN; FIBRINOGEN;

AORTA ARCH SYNDROME; ARTICLE; BLOOD CELL COUNT; CLINICAL ARTICLE; CLINICAL EVALUATION; CORRELATIONAL STUDY; ERYTHROCYTE SEDIMENTATION RATE; FIBRINOGEN BLOOD LEVEL; FOLLOW UP; HUMAN; INFLAMMATION; PATIENT MONITORING; POSITRON EMISSION TOMOGRAPHY; PROTEIN BLOOD LEVEL; SENSITIVITY AND SPECIFICITY; TREATMENT DURATION; ADULT; ALGORITHM; CONTROLLED STUDY; FEMALE; LONGITUDINAL STUDY; MALE; PROSPECTIVE STUDY; RANDOMIZED CONTROLLED TRIAL; SCINTISCANNING;

ADULT; ALGORITHMS; FEMALE; HUMANS; INFLAMMATION; LONGITUDINAL STUDIES; MALE; POSITRON-EMISSION TOMOGRAPHY; PROSPECTIVE STUDIES; TAKAYASU ARTERITIS;

EID: 84858768261     PISSN: 14059940     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (55)

1. Kerr GS, Hallahan CW, Giordano J, et al. Takayasu arteritis. Ann Intern Med 1994; 120:919-929.
2. Takayasu M. Case with unusual changes of the central vessels in the retina. Acta Soc Ophthal Jpn 1908;12:554-555.
3. Waern AU, Andersson P, Hemmingsson A. Takayasu's arteritis: a hospital-region based study on occurrence, treatment and prognosis. Angiology 1983;34(5):311-320.
4. Hall S, Barr W, Lie JT, et al. Takayasu arteritis. A study of 32 North American patients. Medicine (Baltimore) 1985;64:89-99.
5. el-Reshaid K, Varro J, al-Duwairi Q, et al. Takayasu's arteritis in Kuwait. J Trop Med Hyg 1995;98:299-230.
6. Numano F. The story of Takayasu Arteritis. Rheumatology 2002;41:103-106.
7. Nasu T. Pathology of pulseless disease. A systematic study and critical review of twenty-one autopsy cases reported in Japan. Angiology 1963; 14:225-242.
8. Numano F. Vasa Vasoritis, vasculitis and atherosclerosis. Int J Cardiol 2000;75:S1-S8.
9. Kissin EY, Merkel P, Diagnostic imaging in Takayasu arteritis. Curr Opin Rheumatol 2004; 16:31-37.
10. Matsunaga N, Hayashi K, Sakamoto I, et al. Takayasu arteritis: protean radiologic manifestations and diagnosis. Radiographics 1997;17(3): 579-594.
11. Arend W, Michel B, Bloch D, et al. The American College of Rheumatology 1990 criteria for the classification of Takayasu arteritis. Arthritis Rheum 1990; 33: 1129-1134.
12. Johnston S, Lock R, Gompels M. Takayasu arteritis: a review. J Clin Pathol 2002; 55: 481-486.
13. Dabague, Reyes PA. Takayasu Arteritis in Mexico: A 38 year clinical perspective through literature review. Int Journal Cardiology 1996,S54:103-109.
14. Deshpande J. Pathologic features of Takayasu's arteritis (non specific aortoarteritis) Rheumatology 2005; 44(Supplement 3):iii8.
15. W.F. Ng, F. Fantin, C. Ng, et al. Takayasu's arteritis: a cause of prolonged arterial stiffness. Rheumatology 2006;45:741-745.
16. Kerr GS. Takayasu arteritis. Rheum Dis Clin North Am 1995;21:1041-1058.
17. García CL, Olea CI, Talagón MA, et al. Diagnóstico de Arteritis de Takayasu mediante técnicas no invasivas. Radiología 2009;51:28793.
18. Walter MA. [18F] Fluorodeoxyglucose PET in large vessel vasculitis. PET Clin 2006;1:179-189.
19. Ishimori T, Saga T, Mamede M, et al. Increased (18)F-FDG uptake in a model of inflammation: concanavalin A-mediated lymphocyte activation. J Nucl Med 2002;43:658-663.
20. Jones HA, Cadwallader KA, White JF, et al. Dissociation between respiratory burst activity and deoxyglucose uptake in human neutrophil granulocytes: implications for interpretation of (18) F-FDG PET images. J Nucl Med 2002;43:652-657.
21. Turlakow A, Yeung HW, Pui J, et al. Fludeoxyglucose positron emission tomography in the diagnosis of giant cell arteritis. Arch Intern Med 2001;161:1003-1007.
22. Wenger M, Gasser R, Donnemiller E, et al. Images in cardiovascular medicine. Generalized large vessel arteritis visualized by 18 fluorodeoxyglucose- positron emission tomography. Circulation 2003;107:923.
23. Hara M, Goodman PC, Leder RA. FDG-PET finding in early-phase Takayasu arteritis. J Comput Assist Tomogr 1999;23:16-18.
24. Malik IS, Harare O, Al-Nahhas A, et al. Takayasu's arteritis: management of left main stem stenosis. Heart 2003;89:e9.
25. Blockmans D, Stroobants S, Maes A, et al. Positron emission tomography in giant cell arteritis and polymyalgia rheumatica: evidence for inflammation of the aortic arch. Am J Med 2000;108:246-249.
26. Belhocine T, Kaye O, Delanaye P, et al. Maladie de Horton et atteintes arterielles extra-temporales: utilite de la tomographie par emission de positons au 18FDG. A propos de trois observations et revue de la litterature. Rev Med Interne 2002;23:1-8.
27. Hara M, Goodman PC, Leder RA. FDG-PET finding in early phase Takayasu arteritis. J Comput Assist Tomogr 1999; 23:16-18.
28. Belhocine T, Blockmans D, Hustinx R, et al. Imaging of large vessel vasculitis with (18)FDG PET: illusion or reality? A critical review of the literature data. Eur J Nucl Med Mol Imaging 2003;30:1305-1313.
29. Henes JC, Müller M, Krieger J, et al. [18F] FDG-PET/CT as a new and sensitive imaging method for the diagnosis of large vessel vasculitis. Clin Exp Rheumatol 2008;26:S47-52.
30. Bruschi M, De Leonardis F, Govoni M, et al. 18FDG-PET and large vessel vasculitis: preliminary data on 25 patients. Reumatismo 2008;60:212-216.
31. Takahashi M, Momose T, Kameyama M, et al. Abnormal accumulation of [18F]fluorodeoxyglucose in the aortic wall related to inflammatory changes: three case reports. Ann Nucl Med 2006;20:361-364.
32. Akin E, Coen A, Momeni M. PET-CT findings in large vessel vasculitis presenting as FUO, a case report. Clin Rheumatol 2009; 28:737-738.
33. Umekita K, Takajo I, Miyauchi S, et al. [18F]fluorodeoxyglucose positron emission tomography is a useful tool to diagnose the early stage of Takayasu's arteritis and to evaluate the activity of the disease. Mod Rheumatol 2006;16:243-247.
34. Andrews J, Al-Nahhas A, Pennell DJ, et al. Non-invasive imaging in the diagnosis and management of Takayasu's arteritis. Ann Rheum Dis 2004;63:995-1000.
35. Walter MA. [(18)F]fluorodeoxyglucose PET in large vessel vasculitis. Radiol Clin North Am 2007;45:735-744.
36. Rehák Z, Fojtík Z, Stanícek J, et al. 18F-FDG PET in the diagnosis of large vessel vasculitis. Vnitr Lek 2006;52:1037-1044.
37. Lavogiez C, Quéméneur T, Hachulla E, et al. 18FDG PET: a new criterion for disease activity in Takayasu arteritis. Rev Med Interne 2006;27:478-481.
38. Alexánderson E, Soto ME, Ricalde A, et al. Inflammatory activity in Takayasu arteritis. Detection through positron emission tomography (PET). Arch Cardiol Mex 2005;75:82-85.
39. Meave A, Soto ME, Reyes P, et al. Pre-Pulseless Takayasu's Arteritis Evaluated with 18F-FDG Positron Emission Tomography and Gadolinium-Enhanced Magnetic Resonance Angiography. Tex Heart Inst J 2007;34:466-469.
40. Webb M, Chambers A, AL-Nahhas A, et al. The role of 18F-FDG PET in characterising disease activity in Takayasu arteritis. Eur J Nucl Med Mol Imaging 2004;31:627-634.
41. Theron J, Tyler JL. Takayasu's arteritis of the aortic arch: endovascular treatment and correlation with positron emission tomography. Am J Neuroradiol 1987;8:621-626.
42. Yoshihiro N, Yuka Y, Reiko K, et al. FDG PET imaging in Takayasu aortitis before and after treatment. J Nucl Med 2008; 49:265
43. de Leeuw K, Bijl M, Jager PL. Additional value of positron emission tomography in diagnosis and follow-up of patients with large vessel vasculitides. Clin Exp Rheumatol 2004;22:S21-S26.
44. Kobayashi Y, Ishii K, Oda K, et al Aortic Wall Inflammation Due to Takayasu Arteritis Imaged with 18F-FDG PET Coregistered with Enhanced CT. J Nucl Med 2005; 46: 917-922.
45. Lagneau P, Michel JB, Vuong PN. Surgical treatment of Takayasu's disease. Ann Surg 1987;205:157-166.
46. Hoffman GS, Ahmed AE. Surrogate markers of disease activity in patients with Takayasu arteritis. Int J Cardiol 1998;66:S191-194.
47. Gotway M, Araoz P, Macedo T, et al. Imaging Findings in Takayasu's Arteritis. AJR 2005; 184:1945-1950.
48. Canyigit M, Peynircioglu B, Hazirolan T, et al. Imaging characteristics of Takayasu arteritis. Cardiovasc Intervent Radiol 2007;30:711-718.
49. Park JH, Chung JW, Im JG, et al. Takayasu arteritis: evaluation of mural changes in the aorta and pulmonary artery with CT angiography. Radiol 1995;196:89-93.
50. Yoshida S. The spectrum of findings in supra-aortic Takayasu's arteritis as seen on spiral CT angiography and digital subtraction angiography. Cardiovasc Intervent Radiol 2001;24:117-121.
51. Paul JF, Fiessinger JN, Sapoval M, et al. Follow-up electron beam CT for the management of early phase Takayasu arteritis. J Comput Assist Tomogr 2001;25:924-931.
52. Yamada I, Nakagawa T, Himeno Y, et al. Takayasu arteritis: diagnosis with breath-hold contrast enhanced three-dimensional MR angiography. J Magn Reson Imaging 2000;11:481-487.
53. Kumar S, Radhakrishnan S, Phadke RV, et al. Takayasu's arteritis: evaluation with three-dimensional time-of-flight MR angiography. Eur Radiol 1997;7:44-50.
54. Tso E, Flamm SD, White RD, et al. Takayasu arteritis: utility and limitations of magnetic resonance imaging in diagnosis and treatment. Arthritis Rheum 2002;46:1634-1642.
55. Meller J, Strutz F, Siefker U, et al. Early diagnosis and follow-up of aortitis with [(18)F]FDG PET and MRI. Eur J Nucl Med Mol Imaging 2003;30:730-736.